Soru

Zorluk: OrtaPreventive Care and Screening

Following a recent change in her employment benefits, a 50-year-old female schedules an appointment for a comprehensive health evaluation. She mentions that her last medical visit was over a decade ago. She reports feeling well and has no acute or chronic complaints. Her past medical history is notable only for two uncomplicated vaginal deliveries in her twenties. Family history is unremarkable for early-onset malignancies or cardiovascular diseases. She has never smoked, does not consume alcohol, and exercises occasionally. Her blood pressure is 128/78 mmHg, heart rate is 76/min, and body mass index is 33 kg/m^2. Physical examination, including a clinical breast examination and pelvic examination, reveals no abnormalities. Which of the following screening interventions are indicated for this patient at this time? (Select all that apply)

  1. Fecal immunochemical testingCevap
  2. Hemoglobin A1c measurementCevap
  3. C
    Dual-energy x-ray absorptiometry
  4. D
    Low-dose chest computed tomography
  5. E
    Transvaginal ultrasonography

Cevap

The indicated screening interventions for this patient are fecal immunochemical testing and hemoglobin A1c measurement.
Fecal immunochemical testing and hemoglobin A1c measurement are both strongly indicated for this patient. Current United States Preventive Services Task Force (USPSTF) guidelines recommend colorectal cancer screening for all average-risk adults beginning at age 45; therefore, offering a fecal immunochemical test (or another modality such as screening colonoscopy) is appropriate for this 50-year-old patient. Additionally, the USPSTF recommends screening for prediabetes and type 2 diabetes in nonpregnant adults aged 35 to 70 years who are overweight or obese. Given the patient's body mass index of 33 kg/m^2, measuring her hemoglobin A1c (or fasting plasma glucose) is a necessary next step in her preventive care.

Adım Adım Çözüm

1
Analyze the patient's demographic and biometric profile.
The patient is a 50-year-old female with a body mass index of 33 kg/m^2 (obesity) and no history of smoking.
Preventive screening guidelines are highly dependent on age, biological sex, body mass index, and specific lifestyle risk factors.
2
Evaluate the need for cancer screenings.
Colorectal cancer screening is indicated due to her age (>45). Lung cancer screening is not indicated (no smoking history). Ovarian cancer screening is not indicated for average-risk women.
Applying current evidence-based guidelines ensures appropriate resource utilization and minimizes patient harm from false positives.
3
Evaluate the need for metabolic and musculoskeletal screenings.
Screening for type 2 diabetes is indicated due to her age and elevated body mass index. Bone density screening is not indicated as she is under 65 without specific high-risk factors.
Targeted screening catches asymptomatic metabolic conditions early while avoiding unnecessary testing for conditions with low pretest probability.

Anahtar Kavram

Age- and risk-factor-appropriate preventive screening
Bu soruyu puanla